Erratum: An optimised direct lysis method for gene expression studies on low cell numbers (Scientific Reports (2015) 5 (12859) DOI: 10.1038/srep12859);An optimised direct lysis method for gene expression studies on low cell numbers

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Le, Anh Viet Phuong ^a,b   Huang, Dexing ^a   Blick, Tony ^a   Thompson, Erik W ^a,c,d   Dobrovic, Alexander ^a,b,e  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b OLIVIA NEWTON JOHN CANCER RESEARCH INSTITUTE   (Australia)

^c QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^d ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^e LA TROBE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

RNA; TRANSCRIPTOME;

CELL FRACTIONATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; PROCEDURES; TUMOR CELL LINE;

CELL FRACTIONATION; CELL LINE, TUMOR; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; RNA; TRANSCRIPTOME;

EID: 84938770249     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep43075     Document Type: Erratum

References (27)

1. Pantel, K., Alix-Panabieres, C. & Riethdorf, S. Cancer micrometastases. Nature reviews. Clinical oncology 6, 339-351, doi: 10.1038/nrclinonc.2009.44 (2009).
2. Lianidou, E. S. & Markou, A. Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges. Clinical chemistry 57, 1242-1255, doi: 10.1373/clinchem.2011.165068 (2011).
3. Cristofanilli, M. et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. The New England journal of medicine 351, 781-791, doi: 10.1056/NEJMoa040766 (2004).
4. de Bono, J. S. et al. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clinical cancer research: an official journal of the American Association for Cancer Research 14, 6302-6309, doi: 10.1158/1078-0432.ccr-08-0872 (2008).
5. Cohen, S. J. et al. Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. Annals of oncology: official journal of the European Society for Medical Oncology/ESMO 20, 1223-1229, doi: 10.1093/annonc/mdn786 (2009).
6. Lianidou, E. S., Markou, A. & Strati, A. Molecular characterization of circulating tumor cells in breast cancer: challenges and promises for individualized cancer treatment. Cancer metastasis reviews 31, 663-671, doi: 10.1007/s10555-012-9366-8 (2012).
7. Fehm, T. et al. Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells. Breast cancer research : BCR 11, R59, doi: 10.1186/bcr2349 (2009).
8. Strati, A. et al. Gene expression profile of circulating tumor cells in breast cancer by RT-qPCR. BMC cancer 11, 422, doi: 10.1186/1471-2407-11-422 (2011).
9. Usiakova, Z. et al. Circulating tumor cells in patients with breast cancer: monitoring chemotherapy success. In vivo (Athens, Greece) 28, 605-614 (2014).
10. Sieuwerts, A. M. et al. Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex real-time PCR. Breast cancer research and treatment 118, 455-468, doi: 10.1007/s10549-008-0290-0 (2009).
11. Eaton, M. C., Hardingham, J. E., Kotasek, D. & Dobrovic, A. Immunobead RT-PCR: a sensitive method for detection of circulating tumor cells. BioTechniques 22, 100-105 (1997).
12. Hardingham, J. E. et al. Molecular detection of blood-borne epithelial cells in colorectal cancer patients and in patients with benign bowel disease. International journal of cancer. Journal international du cancer 89, 8-13 (2000).
13. Winter, S. C. et al. Long term survival following the detection of circulating tumour cells in head and neck squamous cell carcinoma. BMC cancer 9, 424, doi: 10.1186/1471-2407-9-424 (2009).
14. Raynor, M., Stephenson, S. A., Walsh, D. C., Pittman, K. B. & Dobrovic, A. Optimisation of the RT-PCR detection of immunomagnetically enriched carcinoma cells. BMC cancer 2, 14 (2002).
15. Raynor, M. P. et al. Identification of circulating tumour cells in early stage breast cancer patients using multi marker immunobead RT-PCR. Journal of hematology & oncology 2, 24, doi: 10.1186/1756-8722-2-24 (2009).
16. Svec, D. et al. Direct cell lysis for single-cell gene expression profiling. Frontiers in oncology 3, 274, doi: 10.3389/fonc.2013.00274 (2013).
17. Blick, T. et al. Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer. Journal of mammary gland biology and neoplasia 15, 235-252, doi: 10.1007/s10911-010-9175-z (2010).
18. Perou, C. M. et al. Molecular portraits of human breast tumours. Nature 406, 747-752, doi: doi: 10.1038/35021093 (2000).
19. Hoadley, K. et al. EGFR associated expression profiles vary with breast tumor subtype. BMC Genomics 8, 258 (2007).
20. Xu, L. et al. Direct evidence that bevacizumab, an anti-VEGF antibody, up-regulates SDF1alpha, CXCR4, CXCL6, and neuropilin 1 in tumors from patients with rectal cancer. Cancer research 69, 7905-7910, doi: 10.1158/0008-5472.CAN-09-2099 (2009).
21. Bhati, R. et al. Molecular characterization of human breast tumor vascular cells. The American journal of pathology 172, 1381-1390, doi: 10.2353/ajpath.2008.070988 (2008).
22. Mikulowska-Mennis, A. et al. High-quality RNA from cells isolated by laser capture microdissection. BioTechniques 33, 176-179 (2002).
23. Nagrath, S. et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450, 1235-1239 (2007).
24. Steinert, G. et al. Immune escape and survival mechanisms in circulating tumor cells of colorectal cancer. Cancer research 74, 1694-1704, doi: 10.1158/0008-5472.CAN-13-1885 (2014).
25. Fox, B. C., Devonshire, A. S., Baradez, M.-O., Marshall, D. & Foy, C. A. Comparison of reverse transcription-quantitative polymerase chain reaction methods and platforms for single cell gene expression analysis. Analytical Biochemistry 427, 178-186 (2012).
26. Karabacak, N. M. et al. Microfluidic, marker-free isolation of circulating tumor cells from blood samples. Nat. Protocols 9, 694-710 (2014).
27. Warkiani, M. E. et al. Slanted spiral microfluidics for the ultra-fast, label-free isolation of circulating tumor cells. Lab on a chip 14, 128-137, doi: 10.1039/c3lc50617g (2014).